Merit Financial Group’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
Other funds holding ANVS
FNT
SG
CAMG
SIAP
RSWM
QWM
KAS
WSFS
GCM
CA
Merit Financial Group's ANVS Position: Q2 2026 in Review
Merit Financial Group sold out of Annovis Bio (ANVS) in Q2 2026, closing a stake of 81,316 shares — an estimated $181K sold.
Merit Financial Group first reported a position in ANVS in Q3 2022 and held it in 15 quarters. The position peaked at $661K in Q1 2023. 13 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.
- Merit Financial Group reported no remaining Annovis Bio position as of Q2 2026 after selling out during the quarter.
- Merit Financial Group sold 81,316 Annovis Bio shares in Q2 2026, an estimated $181K.
- Merit Financial Group first reported a position in Annovis Bio in Q3 2022 and held it in 15 quarters.
- Merit Financial Group's Annovis Bio position peaked at $661K in Q1 2023.
- 13 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.
Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.